Nifty

:

23865.75

Sensex

:

76478.67

-80.50 (-0.34%)
-249.70 (-0.33%)

Login

Nifty
Sensex

:
:

23865.75
76478.67

-80.50 (-0.34%)
-249.70 (-0.33%)

Aarti Pharmalabs Ltd.

Pharmaceuticals & Drugs

Rating :

48/99

BSE: 543748 | NSE: AARTIPHARM

Watchlist

NSE BSE

680.05

30-Jun-2026

Open
High
Low
Previous Close

676.9
694.45
673
675.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

252619
173260671.95
971
585

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,176.66
35.35
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,852.67
0.51%
2.91

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
2.83

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
6.31

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
12.08

P:E (Median)

8 Years
5 Years
3 Years

-
-
26.15

P:BV (Average)

8 Years
5 Years
3 Years

-
-
3.09

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
14.89

Earnings Forecasts:

(Updated: 27-06-2026)

Description 2026 2027 2028 2029
Adj EPS -1.2 26.13 26.75 25.5
P/E Ratio -566.71 26.03 25.42 26.67
Revenue - 2088.7 2409.5 2368.9
EBITDA - 446.95 495.65 529.7
Net Income - 233.8 236.15 216.2
ROA - - - -
P/B Ratio - 3.01 2.72 2.49
ROE - 11.05 9.95 9.3
FCFF - 107.1 -0.1 179.8
FCFF Yield - 1.55 0 2.61
Net Debt - - - -
BVPS - 225.8 250.4 273.4

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 579.70 529.62 9.46% 425.25 470.95 -9.70% 417.29 377.29 10.60% 375.31 393.49 -4.62%
Expenses 462.63 388.96 18.94% 322.31 355.96 -9.45% 343.31 292.52 17.36% 280.18 309.83 -9.57%
EBITDA 117.07 140.66 -16.77% 102.94 114.99 -10.48% 73.98 84.77 -12.73% 95.13 83.65 13.72%
EBIDTM 20.20% 26.56% 24.21% 24.42% 17.73% 22.47% 25.35% 21.26%
Other Income 10.53 -0.04 - -0.37 11.94 - 3.15 2.95 6.78% 1.60 2.11 -24.17%
Interest 16.86 6.29 168.04% 12.58 9.70 29.69% 10.66 5.39 97.77% 6.80 4.25 60.00%
Depreciation 28.16 20.83 35.19% 28.62 21.04 36.03% 24.77 18.89 31.13% 22.76 18.29 24.44%
PBT 82.59 113.50 -27.23% 58.58 96.18 -39.09% 41.70 63.43 -34.26% 67.17 63.23 6.23%
Tax 20.55 24.66 -16.67% 14.74 22.66 -34.95% 10.77 15.60 -30.96% 15.95 16.08 -0.81%
PAT 62.03 88.85 -30.19% 43.85 73.52 -40.36% 30.93 47.84 -35.35% 51.22 47.14 8.66%
PATM 10.70% 16.78% 10.31% 15.61% 7.41% 12.68% 13.65% 11.98%
EPS 6.84 9.80 -30.20% 4.83 8.11 -40.44% 3.41 5.27 -35.29% 5.65 5.20 8.65%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 582.64 563.78 3.35% 432.27 537.78 -19.62% 418.34 458.03 -8.67% 386.19 555.49 -30.48%
Expenses 469.51 420.62 11.62% 329.97 409.17 -19.36% 343.62 364.35 -5.69% 290.95 459.03 -36.62%
EBITDA 113.13 143.16 -20.98% 102.31 128.61 -20.45% 74.72 93.67 -20.23% 95.24 96.46 -1.26%
EBIDTM 19.42% 25.39% 23.67% 23.91% 17.86% 20.45% 24.66% 17.36%
Other Income 8.05 0.86 836.05% -0.37 5.03 - 0.05 4.48 -98.88% 1.60 2.22 -27.93%
Interest 16.86 6.58 156.23% 12.58 9.97 26.18% 10.67 5.51 93.65% 6.80 4.83 40.79%
Depreciation 28.16 22.82 23.40% 28.62 23.04 24.22% 24.77 20.88 18.63% 22.79 20.17 12.99%
PBT 76.17 114.62 -33.55% 57.94 100.63 -42.42% 39.34 71.77 -45.19% 67.25 73.68 -8.73%
Tax 20.55 26.28 -21.80% 14.91 26.64 -44.03% 10.77 17.14 -37.16% 15.95 18.22 -12.46%
PAT 55.61 88.34 -37.05% 43.03 73.99 -41.84% 28.57 54.62 -47.69% 51.30 55.45 -7.48%
PATM 9.54% 15.67% 9.95% 13.76% 6.83% 11.93% 13.28% 9.98%
EPS 6.74 9.75 -30.87% 5.29 8.16 -35.17% 3.08 6.03 -48.92% 5.46 6.12 -10.78%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 1,797.55 1,771.35 1,502.13 1,511.25 941.02 0.00 0.00 Net Sales Growth 1.48% 17.92% -0.60% 60.60% 0 0 Cost Of Goods Sold 821.14 879.26 751.97 817.93 451.66 0.00 0.00 Gross Profit 976.41 892.09 750.16 693.32 489.36 0.00 0.00 GP Margin 54.32% 50.36% 49.94% 45.88% 52.00% 0 0 Total Expenditure 1,408.43 1,344.81 1,155.97 1,202.91 761.24 0.00 0.02 Power & Fuel Cost - 80.19 82.92 74.22 69.73 0.00 0.00 % Of Sales - 4.53% 5.52% 4.91% 7.41% 0 0 Employee Cost - 139.82 120.15 113.92 79.98 0.00 0.00 % Of Sales - 7.89% 8.00% 7.54% 8.50% 0 0 Manufacturing Exp. - 133.24 98.22 96.20 132.62 0.00 0.00 % Of Sales - 7.52% 6.54% 6.37% 14.09% 0 0 General & Admin Exp. - 43.88 37.35 29.30 6.98 0.00 0.02 % Of Sales - 2.48% 2.49% 1.94% 0.74% 0 0 Selling & Distn. Exp. - 51.97 49.19 48.54 20.25 0.00 0.00 % Of Sales - 2.93% 3.27% 3.21% 2.15% 0 0 Miscellaneous Exp. - 16.45 16.17 22.80 0.01 0.00 0.00 % Of Sales - 0.93% 1.08% 1.51% 0.00% 0 0 EBITDA 389.12 426.54 346.16 308.34 179.78 0.00 -0.02 EBITDA Margin 21.65% 24.08% 23.04% 20.40% 19.10% 0 0 Other Income 14.91 14.49 11.01 1.28 2.51 0.00 0.00 Interest 46.90 25.63 16.63 20.49 11.34 0.00 0.00 Depreciation 104.31 79.06 66.01 55.77 37.23 0.00 0.00 PBT 250.04 336.34 274.52 233.36 133.73 0.00 -0.02 Tax 62.01 78.99 73.87 61.63 27.00 0.00 0.00 Tax Rate 24.80% 23.49% 26.91% 26.41% 20.19% 0.00% 0.00% PAT 188.03 257.35 200.65 171.73 106.73 0.00 -0.02 PAT before Minority Interest 188.03 257.35 200.65 171.73 106.73 0.00 -0.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.46% 14.53% 13.36% 11.36% 11.34% 0 0 PAT Growth -26.94% 28.26% 16.84% 60.90% 0 - EPS 20.73 28.37 22.12 18.93 11.77 0.00 0.00

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Net Sales 1,819.44 2,115.07 1,852.61 1,945.23 1,199.94 0.00 Net Sales Growth -13.98% 14.17% -4.76% 62.11% 0 Cost Of Goods Sold 834.86 1,127.88 1,020.71 1,169.76 637.67 0.00 Gross Profit 984.58 987.20 831.89 775.48 562.27 0.00 GP Margin 54.11% 46.67% 44.90% 39.87% 46.86% 0 Total Expenditure 1,434.05 1,650.70 1,466.56 1,603.18 994.67 0.00 Power & Fuel Cost - 81.32 84.03 75.10 90.00 0.00 % Of Sales - 3.84% 4.54% 3.86% 7.50% 0 Employee Cost - 148.65 128.03 121.32 85.20 0.00 % Of Sales - 7.03% 6.91% 6.24% 7.10% 0 Manufacturing Exp. - 141.94 105.52 98.78 145.95 0.00 % Of Sales - 6.71% 5.70% 5.08% 12.16% 0 General & Admin Exp. - 49.08 40.51 30.20 8.13 0.00 % Of Sales - 2.32% 2.19% 1.55% 0.68% 0 Selling & Distn. Exp. - 79.71 68.88 74.83 27.38 0.00 % Of Sales - 3.77% 3.72% 3.85% 2.28% 0 Miscellaneous Exp. - 22.12 18.88 33.20 0.34 0.00 % Of Sales - 1.05% 1.02% 1.71% 0.03% 0 EBITDA 385.40 464.37 386.05 342.05 205.27 0.00 EBITDA Margin 21.18% 21.96% 20.84% 17.58% 17.11% 0 Other Income 9.33 10.12 4.90 2.32 4.19 0.00 Interest 46.91 26.90 17.21 21.05 11.96 0.00 Depreciation 104.34 86.90 73.24 62.54 42.12 0.00 PBT 240.70 360.69 300.49 260.77 155.38 0.00 Tax 62.18 88.28 83.59 67.28 33.13 0.00 Tax Rate 25.83% 24.48% 27.82% 25.80% 21.32% 0.00% PAT 178.51 272.40 216.90 193.49 122.25 0.00 PAT before Minority Interest 178.51 272.40 216.90 193.49 122.25 0.00 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.81% 12.88% 11.71% 9.95% 10.19% 0 PAT Growth -34.47% 25.59% 12.10% 58.27% 0 EPS 19.68 30.03 23.91 21.33 13.48 0.00

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 1,843.87 1,621.46 1,438.58 1,284.28 0.23 0.23 Share Capital 45.32 45.31 45.31 0.25 0.25 0.25 Total Reserves 1,796.82 1,575.92 1,393.27 1,238.71 -0.02 -0.02 Non-Current Liabilities 257.40 119.87 74.04 60.88 0.00 0.02 Secured Loans 103.56 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 7.09 5.28 4.66 0.00 0.00 0.00 Current Liabilities 622.33 555.58 463.75 481.67 0.02 0.00 Trade Payables 248.97 254.79 212.50 131.61 0.00 0.00 Other Current Liabilities 71.52 43.76 36.20 8.98 0.00 0.00 Short Term Borrowings 291.30 250.80 206.71 324.62 0.02 0.00 Short Term Provisions 10.54 6.24 8.33 16.46 0.00 0.00 Total Liabilities 2,723.60 2,296.91 1,976.37 1,826.83 0.25 0.25 Net Block 1,059.32 953.33 848.40 701.12 0.00 0.00 Gross Block 1,653.44 1,472.15 1,303.76 1,100.71 0.00 0.00 Accumulated Depreciation 594.12 518.82 455.37 399.59 0.00 0.00 Non Current Assets 1,510.81 1,162.85 1,010.15 936.56 0.00 0.00 Capital Work in Progress 368.70 136.92 101.90 187.37 0.00 0.00 Non Current Investment 41.15 43.83 42.67 39.87 0.00 0.00 Long Term Loans & Adv. 41.63 28.77 17.18 8.21 0.00 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,212.80 1,134.06 966.22 890.27 0.25 0.25 Current Investments 15.88 17.83 12.81 0.00 0.00 0.00 Inventories 544.22 582.15 537.68 444.38 0.00 0.00 Sundry Debtors 552.59 448.82 371.67 304.22 0.00 0.00 Cash & Bank 3.52 4.43 0.37 56.50 0.25 0.25 Other Current Assets 96.58 13.97 7.18 11.53 0.00 0.00 Short Term Loans & Adv. 83.01 66.86 36.51 73.65 0.00 0.00 Net Current Assets 590.47 578.48 502.47 408.60 0.23 0.25 Total Assets 2,723.61 2,296.91 1,976.37 1,826.83 0.25 0.25

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 1,989.91 1,757.04 1,558.49 1,386.48 0.23 Share Capital 45.32 45.31 45.31 0.25 0.25 Total Reserves 1,942.86 1,711.50 1,513.17 1,340.91 -0.02 Non-Current Liabilities 259.45 130.68 84.91 72.76 0.00 Secured Loans 103.56 0.04 0.18 0.55 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 8.12 6.06 5.36 0.00 0.00 Current Liabilities 657.05 694.39 600.62 580.67 0.02 Trade Payables 277.83 378.32 339.50 214.59 0.00 Other Current Liabilities 73.54 45.84 38.33 11.89 0.00 Short Term Borrowings 292.80 263.92 213.78 337.73 0.02 Short Term Provisions 12.88 6.31 9.01 16.46 0.00 Total Liabilities 2,906.41 2,582.11 2,244.02 2,039.91 0.25 Net Block 1,136.57 1,033.33 925.84 782.09 0.00 Gross Block 1,795.66 1,609.29 1,431.25 1,225.00 0.00 Accumulated Depreciation 659.09 575.96 505.41 442.90 0.00 Non Current Assets 1,584.24 1,236.46 1,081.02 1,011.75 0.00 Capital Work in Progress 374.35 136.92 101.87 187.37 0.00 Non Current Investment 29.24 36.78 35.52 32.23 0.00 Long Term Loans & Adv. 44.08 29.44 17.78 10.07 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 Current Assets 1,322.17 1,345.64 1,163.01 1,028.15 0.25 Current Investments 47.56 70.39 50.99 0.00 0.00 Inventories 587.58 642.86 602.04 475.45 0.00 Sundry Debtors 575.40 519.34 450.10 376.66 0.00 Cash & Bank 8.65 24.07 12.19 83.27 0.25 Other Current Assets 102.98 17.01 7.70 10.74 0.00 Short Term Loans & Adv. 87.28 71.97 39.98 82.03 0.00 Net Current Assets 665.12 651.25 562.38 447.48 0.23 Total Assets 2,906.41 2,582.10 2,244.03 2,039.90 0.25

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity 340.01 183.69 215.88 -64.84 PBT 336.34 274.52 233.36 133.73 Adjustment 109.05 80.71 76.87 46.08 Changes in Working Capital -46.88 -124.55 -37.61 -229.65 Cash after chg. in Working capital 398.51 230.68 272.61 -49.84 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -58.50 -46.99 -56.73 -15.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -419.80 -184.40 -115.55 -133.54 Net Fixed Assets -413.07 -203.41 -117.58 Net Investments 4.63 -6.18 -15.61 Others -11.36 25.19 17.64 Cash from Financing Activity 78.63 4.40 -156.53 254.63 Net Cash Inflow / Outflow -1.16 3.70 -56.20 56.25 Opening Cash & Equivalents 4.00 0.30 56.50 0.25 Closing Cash & Equivalent 2.84 4.00 0.30 56.50

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity 331.56 216.35 250.12 -43.70 PBT 360.69 300.49 260.77 155.38 Adjustment 121.47 94.65 83.35 52.41 Changes in Working Capital -86.07 -121.85 -31.63 -230.36 Cash after chg. in Working capital 396.09 273.29 312.50 -22.57 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -64.53 -56.94 -62.38 -21.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -413.90 -214.56 -157.80 -138.74 Net Fixed Assets -413.07 -203.41 -117.58 Net Investments 4.63 -6.18 -15.61 Others -5.46 -4.97 -24.61 Cash from Financing Activity 65.44 9.72 -163.46 260.38 Net Cash Inflow / Outflow -16.90 11.51 -71.15 77.94 Opening Cash & Equivalents 23.63 12.12 83.27 5.33 Closing Cash & Equivalent 6.73 23.63 12.12 83.27

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 203.25 178.89 158.74 49558.52 ROA 10.25% 9.39% 9.03% 11.68% ROE 14.86% 13.11% 12.83% 17.23% ROCE 17.61% 16.55% 15.60% 18.03% Fixed Asset Turnover 1.13 1.08 1.26 0.85 Receivable days 103.17 99.68 81.62 118.00 Inventory Days 116.05 136.05 118.59 172.36 Payable days 104.56 113.41 76.78 53.18 Cash Conversion Cycle 114.66 122.33 123.44 237.18 Total Debt/Equity 0.21 0.15 0.14 0.26 Interest Cover 14.12 17.50 12.39 12.79

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 219.36 193.85 171.97 53646.60 ROA 9.93% 8.99% 9.03% 11.98% ROE 14.55% 13.08% 13.35% 18.23% ROCE 17.59% 16.75% 16.11% 19.40% Fixed Asset Turnover 1.24 1.22 1.46 0.98 Receivable days 94.46 95.50 77.57 114.57 Inventory Days 106.17 122.63 101.09 144.62 Payable days 106.17 128.34 86.45 61.41 Cash Conversion Cycle 94.46 89.79 92.21 197.78 Total Debt/Equity 0.20 0.15 0.14 0.25 Interest Cover 14.41 18.46 13.39 13.99

Top Investors:

life insurance corporation of india

ntasain discovery master fund

nishant pradip shah

investor education and protection fund (iepf)

Annual Reports:

News Update:

Aarti Pharmalabs inaugurates additional manufacturing block at Tarapur Unit 5
1st Jul 2026, 09:58 AM

The company has successfully obtained all the necessary permissions and approvals to start the facility
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback